• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Weaning Patients Off of PPIs

by Amy E. Hamaker • October 14, 2016

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

The term for weaning patients off of medication is “deprescribing,” a process that involves slowly withdrawing and stopping the medication. “Unfortunately, there really isn’t much information in terms of a ‘gold standard’ on what weaning protocols are the most effective,” said Karla O’Dell, MD, assistant professor of clinical otolaryngology at the University of Southern California Voice Center in Los Angeles. “Anecdotally, I think most use a de-escalation approach: If a patient is on a maximum dose twice a day, you would decrease the dose, then go from twice a day to once a day. Some physicians will transition patients from a PPI to an H2 blocker, and then stop completely.”

You Might Also Like

  • High BMI a Significant Indicator of PPI Weaning Failure
  • Non-Acidic Reflux Explains Lack of Response to H2 Blockers and PPIs
  • Diet Therapy an Effective Alternative to Medication in Some Patients with Laryngopharyngeal Reflux
  • Some Laryngopharyngeal Reflux Resists PPI Treatment
Explore This Issue
October 2016

Karla O’Dell, MDBecause there is no cut-and-dried diagnostic for LPR, some physicians use a PPI as a sort of diagnostic test. But we don’t always think about getting patients back off of the PPI if that test fails. —Karla O’Dell, MD

Several studies have looked at ways to wean patients off of PPI therapy. Clark Rosen, MD, a professor of otolaryngology at the University of Pittsburgh School of Medicine in Pittsburgh, and his colleagues presented a retrospective review at the 2016 Triological Society meeting at the Combined Otolaryngology Spring Meetings (COSM) in Chicago. Thirty-seven patients with suspected LPR were instructed to wean from PPI using a standardized weaning protocol after successful treatment of their symptoms. Twenty-two of the 37 patients (59%) remained symptom free after deprescription. Fifteen patients (41%) had symptom recurrence, and 12 (32%) needed to go back on a PPI. The researchers also found that high body mass index was predictive of a failure to wean off the medication.

A recently published retrospective cohort examined 188 patients treated for LPR between April 1, 2011, and April 30, 2014, at the Queens Hospital Center Otolaryngology Clinic in New York City (Am J Otolaryngol. 2016;37:245-50). The clinic had instituted a standardized clinical protocol for LPR diagnosis and management in 2012, involving diagnosis using clinical judgment guided by the Reflux Symptom Index and Reflux Finding Score, treatment with PPIs, and weaning therapy after symptom resolution. This allowed the researchers to distinguish between patients who had been treated through the protocol and those who had not. The primary outcome measure was complete response to therapy and the secondary outcome measures were any response (complete or partial) and successful wean off PPI therapy.

The patients who were treated with the LPR protocol had higher rates of complete response, although there was no statistically significant difference in rates of any response (complete or partial) between the two groups, and were more likely to be successfully weaned off of PPI therapy than those who were not treated following the protocol. The 12-month wean rate was 52% for patients treated with the protocol versus 23% for patients treated without.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Home Slider, Laryngology, Practice Focus Tagged With: deprescribing, PPI, proton pump inhibitorIssue: October 2016

You Might Also Like:

  • High BMI a Significant Indicator of PPI Weaning Failure
  • Non-Acidic Reflux Explains Lack of Response to H2 Blockers and PPIs
  • Diet Therapy an Effective Alternative to Medication in Some Patients with Laryngopharyngeal Reflux
  • Some Laryngopharyngeal Reflux Resists PPI Treatment

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use AI-powered scribes for documentation?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • How to: Positioning for Middle Cranial Fossa Repair of Superior Semicircular Canal Dehiscence

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • The Importance of Time Away
    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 
    • Reflections from a Past President of the Triological Society
    • ENT Surgeons Explore the Benefits and Challenges of AI-Powered Scribes: Revolutionizing Documentation in Healthcare
    • How To: Open Expansion Laryngoplasty for Combined Glottic and Subglottic Stenosis

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939